Abstract 3093: Expression of DLL3 in metastatic melanoma, glioblastoma and high-grade extrapulmonary neuroendocrine carcinomas as potential indications for rovalpituzumab tesirine (Rova-T; SC16LD6.5), a delta-like protein 3 (DLL3)-targeted antibody drug conjugate (ADC)

已取消 20 由 Chang 发布于 2025/4/1 9:27:06

DOI:10.1158/1538-7445.AM2017-3093
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1158/1538-7445.AM2017-3093
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Association for Cancer Research (AACR)

Abstract：Expression of DLL3 was examined in additional tumor types, as it was found to be highly expressed in tumor-initiating cells (TIC) in small cell lung cancer (SCLC), where a DLL3-targeted anti

应助信息

2025-04-01

Book学术机器人

2025/4/1 9:27:06 未找到该文献，机器人已退出，请等待人工下载

2025/4/1 9:27:06 Book学术AI机器人收到请求，开始寻找文献

2025/4/1 9:27:06 已向机器人发送请求

2025-04-01

Chang 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Locking-Fluorescence Signals Regulated CRISPR/Cas12a Biosensor Based on Metal–Organic Framework for Sensitive Detection of Salmonella typhimurium